[POISONING BY PSYCHOPHARMACOLOGICAL DRUGS IN AZERBAIJAN: THE RESULTS OF 8-YEAR PROSPECTIVE OBSERVATION].
Afandiyev I, Azizov V.
Georgian Med News. 2017 Nov;(272):138-144.
Tricyclic antidepressant toxicity.
Rose JB.
Clin Toxicol. 1977;11(4):391-402. doi: 10.3109/15563657708988202.
Postmortem toxicology of carbamazepine.
Klys M, Bystrowska B, Bujak-Gizycka B.
J Anal Toxicol. 2003 May-Jun;27(4):243-8. doi: 10.1093/jat/27.4.243.
Carbamazepine-induced hyperglycemia: A rare case report.
Harika V, Parveen S, Venkatasubbaiah M, Varma KVS, Devasree S.
Indian J Pharmacol. 2019 Sep-Oct;51(5):352-353. doi: 10.4103/ijp.IJP_537_18. Epub 2019 Nov 26.
Experimental and theoretical insight into carbamazepine degradation by chlorine-based advanced oxidation processes: Efficiency, energy consumption, mechanism and DBPs formation.
Liu C, How ZT, Ju Y, Feng L, Ren X, Gamal El-Din M.
J Environ Sci (China). 2024 May;139:72-83. doi: 10.1016/j.jes.2023.05.012. Epub 2023 May 22.
Carbamazepine-induced hepatitis in a patient with cervical myelopathy.
Kong KH.
Arch Phys Med Rehabil. 1996 Mar;77(3):305-6. doi: 10.1016/s0003-9993(96)90117-3.
Dibenzazepine combats acute liver injury in rats via amendments of Notch signaling and activation of autophagy.
Ahmed LA, Abd El-Rhman RH, Gad AM, Hassaneen SK, El-Yamany MF.
Naunyn Schmiedebergs Arch Pharmacol. 2021 Feb;394(2):337-348. doi: 10.1007/s00210-020-01977-0. Epub 2020 Sep 28.
Tricyclic antidepressant tranquilizers (dibenzazepine compounds).
Hall R.
Bull Natl Clgh Poison Control Cent. 1970 May-Jun:1-12.
Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB, Janssen TJ, Hekster YA, Termond EF, van de Dries AC, Wijnands WJ.
Ther Drug Monit. 1986;8(3):297-304. doi: 10.1097/00007691-198609000-00011.
Pharmacokinetic aspects of carbamazepine and its two major metabolites in plasma during overdosage.
Hundt HK, Aucamp AK, Müller FO.
Hum Toxicol. 1983 Oct;2(4):607-14. doi: 10.1177/096032718300200405.
